PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

111 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Vreka, M. et al.: IkB kinase a Is required for development and progression of KRAS-mutant lung adenocarcinoma. Cancer Res. 78, 2939-2951 (2018)
22.
Wierling, C.* et al.: CanPathPro-development of a platform for predictive pathway modelling using genetically engineered mouse models. Cancer Res. 78 (2018)
23.
Zoni, E.* et al.: Metabolic signature in lethal vs. nonlethal prostate cancer. Cancer Res. 78, 61-62 (2018)
24.
Gires, O.: EGFR-dependent regulated intramembrane proteolysis of EpCAM - Letter. Cancer Res. 77, 1775-1776 (2017)
25.
Koch, M. et al.: Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer. Cancer Res. 77, 623-631 (2017)
26.
Schlenker, R. et al.: Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy. Cancer Res. 77, 3577-3590 (2017)
27.
Fehringer, G.* et al.: Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76, 5103-5114 (2016)
28.
González-Valllinas, M.* et al.: Abstract 1945: Identification of a miRNA/mRNA network driving non-small cell lung cancer (NSCLC) dissemination. Cancer Res. 76 (2016)
29.
Hatzl, S.* et al.: Increased expression of miR-23a mediates a loss of expression in the RAF kinase inhibitor protein RKIP. Cancer Res. 76, 3644-3654 (2016)
30.
Mall, S.* et al.: Immuno-PET imaging of engineered human T cells in tumors. Cancer Res. 76, 4113-4123 (2016)
31.
Patel, Y.M.* et al.: Novel association of genetic markers affecting CYP2A6 activity and lung cancer risk. Cancer Res. 76, 5768-5776 (2016)
32.
Scheel, C. et al.: A force-sensitive organoid assay to quantify regenerative potential of single primary human mammary cells. Cancer Res. 76:P1-06-02 (2016)
33.
Wolf, B.* et al.: Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma. Cancer Res. 76, 5550-5561 (2016)
34.
Anastasov, N. et al.: Three-dimensional microtissues as phenotypic screening model to identify radiation modifiers for breast cancer. Cancer Res. 75:1810 (2015)
35.
Bigalke, I.* et al.: A new generation of dendritic cells to improve cancer therapy shows prolonged progression-free survival in patients with solid tumors. Cancer Res. 75:2516 (2015)
36.
Höfig, I. et al.: Generation of 3D-microtissues suitable for drug screening with lentivirally GFP-labelled CD44+CD24-breast cancer cells enriched by irradiation. Cancer Res. 75:1408 (2015)
37.
Taruttis, A. ; van Dam, G.M.* & Ntziachristos, V.: Mesoscopic and macroscopic optoacoustic imaging of cancer. Cancer Res. 75, 1548-1559 (2015)
38.
Toma, M.I.* et al.: Accumulation of tolerogenic human 6-sulfo LacNAc plus dendritic cells in renal cell carcinoma is associated with poor prognosis. Cancer Res. 75:1278 (2015)
39.
Endesfelder, D. et al.: Chromosomal instability selects gene copy number variants encoding core regulators of proliferation in ER+ breast cancer. Cancer Res. 74, 4853-4863 (2014)
40.
Faucz, F.R.* et al.: Constitutive activation of PRKACA in adrenal Cushing's syndrome. Cancer Res. 74:LB-182 (2014)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮